Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer.
Saved in:
| Title: | Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer. |
|---|---|
| Authors: | Rugo HS; University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA., Umanzor GA; Centro Oncológico Integral with DEMEDICA, San Pedro Sula, Honduras., Barrios FJ; American Cancer Center, Guatemala City, Guatemala., Vasallo RH; Clinical Research RD, Santo Domingo, Dominican Republic., Chivalan MA; CELAN Clínica Médica, Guatemala City, Guatemala., Bejarano S; Excel Medica, San Pedro Sula, Honduras., Ramírez JR; Sanatorio Centro Regional de Sub-Especialidades Médicas (CRESEM), Quetzaltenango, Guatemala., Fein L; Instituto de Oncología de Rosario, Rosario, Argentina., Kowalyszyn RD; Centro de Investigaciones Clínicas, Clínica Viedma, Viedma, Argentina., Kramer ED; Athenex, Inc, Buffalo, NY., Wang H; Athenex, Inc, Buffalo, NY., Kwan MR; Athenex, Inc, Buffalo, NY., Cutler DL; Athenex, Inc, Buffalo, NY. |
| Corporate Authors: | Oraxol Study Consortium Investigators |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 01; Vol. 41 (1), pp. 65-74. Date of Electronic Publication: 2022 Jul 20. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1527-7755 |
|---|---|
| DOI: | 10.1200/JCO.21.02953 |
